HDC, SPM enter into development and licensing agreements with Quest Diagnostics

From Quest DiagnosticsMar 17 2010

Health Discovery Corporation (OTCBB: HDVY) (HDC) and Smart Personalized Medicine, LLC (SPM) announced today that they have entered into development and related licensing agreements with Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic testing, information and services. Under the agreements, Quest Diagnostics will develop new laboratory tests for aiding in the selection of breast cancer therapies.

Under the terms of the agreements, HDC and SPM will receive upfront licensing payments, development fees and royalties on a per test basis from Quest Diagnostics.

In February 2009, Health Discovery Corporation announced that it had licensed rights to develop a new urine-based test for clinically significant prostate cancer to Quest Diagnostics.

Source:

Health Discovery Corporation

Posted in: Device / Technology News

Tags: Biomarker, Breast Cancer, Cancer, Diagnostic, Diagnostics, Laboratory, Medicine, Pathology, Precision Medicine, Prostate, Prostate Cancer, Radiology

Comments (0)

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

APA
Quest Diagnostics. (2019, June 19). HDC, SPM enter into development and licensing agreements with Quest Diagnostics. News-Medical. Retrieved on April 19, 2024 from https://www.news-medical.net/news/20100317/HDC-SPM-enter-into-development-and-licensing-agreements-with-Quest-Diagnostics.aspx.
MLA
Quest Diagnostics. "HDC, SPM enter into development and licensing agreements with Quest Diagnostics". News-Medical. 19 April 2024. <https://www.news-medical.net/news/20100317/HDC-SPM-enter-into-development-and-licensing-agreements-with-Quest-Diagnostics.aspx>.
Chicago
Quest Diagnostics. "HDC, SPM enter into development and licensing agreements with Quest Diagnostics". News-Medical. https://www.news-medical.net/news/20100317/HDC-SPM-enter-into-development-and-licensing-agreements-with-Quest-Diagnostics.aspx. (accessed April 19, 2024).
Harvard
Quest Diagnostics. 2019. HDC, SPM enter into development and licensing agreements with Quest Diagnostics. News-Medical, viewed 19 April 2024, https://www.news-medical.net/news/20100317/HDC-SPM-enter-into-development-and-licensing-agreements-with-Quest-Diagnostics.aspx.